Structure–activity relationship of caffeic acid phenethyl ester analogs as new 5‐lipoxygenase inhibitors

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Chemical Biology and Drug Design

• Publication date

  2017-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/cbdd.12874PMID 27717142
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors.

  2015cited by this paper
• Clicked Cinnamic/Caffeic Esters and Amides as Radical Scavengers and 5-Lipoxygenase Inhibitors

  2014cited by this paper
• In Vivo and In Vitro Antıneoplastic Actions of Caffeic Acid Phenethyl Ester (CAPE): Therapeutic Perspectives

  2013influential reference
• Anticancer Effect of Caffeic Acid Phenethyl Ester

  2012cited by this paper
• The anticancer activity of propolis.

  2012influential reference
• Synthesis and Antiradical/Antioxidant Activities of Caffeic Acid Phenethyl Ester and Its Related Propionic, Acetic, and Benzoic Acid Analogues

  2012cited by this paper
• Caffeic Acid Phenethyl Ester and Its Amide Analogue Are Potent Inhibitors of Leukotriene Biosynthesis in Human Polymorphonuclear Leukocytes

  2012cited by this paper
• Cytotoxic constituents of propolis inducing anticancer effects: a review

  2011cited by this paper
• 5-Lipoxygenase inhibitors: a review of recent developments and patents

  2010influential reference
• Synthesis and 5-lipoxygenase inhibitory activity of new cinnamoyl and caffeoyl clusters.

  2009cited by this paper
• Caffeoyl and cinnamoyl clusters with anti-inflammatory and anti-cancer effects. Synthesis and structure–activity relationship

  2009cited by this paper
• Lipoxygenase inhibitors: A comparative QSAR study review and evaluation of new QSARs

  2008cited by this paper
• Zileuton: clinical implications of 5‐Lipoxygenase inhibition in severe airway disease

  2007cited by this paper
• Leukotrienes.

  2007cited by this paper
• Synthesis and evaluation of new phenolic-based antioxidants: Structure–activity relationship

  2007cited by this paper
• Effect of the water extracts of propolis on stimulation and inhibition of different cells

  2007cited by this paper
• Mechanisms of disease: Leukotrienes

  2007cited by this paper
• Involvement of the 5-lipoxygenase/leukotriene A4 hydrolase pathway in 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch, and inhibition of carcinogenesis by its inhibitors.

  2006cited by this paper
• Synthesis of selenium-containing polyphenolic acid esters and evaluation of their effects on antioxidation and 5-lipoxygenase inhibition.

  2005cited by this paper
• Pharmacological intervention with 5-lipoxygenase: new insights and novel compounds

  2005cited by this paper
• Leukotriene A4 hydrolase in rat and human esophageal adenocarcinomas and inhibitory effects of bestatin.

  2003influential reference
• Benefit-Risk Assessment of Antileukotrienes in the Management of Asthma

  2003influential reference
• Chemical syntheses of caffeoyl and 5-OH coniferyl aldehydes and alcohols and determination of lignin O-methyltransferase activities in dicot and monocot species.

  2001cited by this paper
• Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells.

  1998influential reference
• Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents.

  1998cited by this paper
• Antioxidant Activities of Caffeic Acid and Its Related Hydroxycinnamic Acid Compounds

  1997cited by this paper
• Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group.

  1996cited by this paper
• The effect of propolis and its components on eicosanoid production during the inflammatory response.

  1996cited by this paper
• Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6-month randomized multicenter trial

  1996influential reference
• A new general method for preparation of N-methoxy-N-methylamides. Application in direct conversion of an ester to a ketone

  1995cited by this paper
• Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties

  1993cited by this paper
• Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis

  1988influential reference
• Utilisation de la guanidine comme agent désacétylant sélectif:une méthode de désacétylation instantanée applicable aux sucres

  1987cited by this paper
• A GC/MS Study of the Propolis Phenolic Constituents

  1987cited by this paper
• Caffeic acid is a selective inhibitor for leukotriene biosynthesis.

  1984cited by this paper
• Caffeic acid is a selective inhibitor for leukotriene biosynthesis

  1984cited by this paper
• Selective inhibition of 5‐lipoxygenase by natural compounds isolated from Chinese plants, Artemisia rubripes Nakai

  1983influential reference
• Release and metabolism of arachidonic acid in human neutrophils.

  1981cited by this paper

• Phenolic Quantification, In Vitro Biological Activities and In Silico Studies of Ultrasound Assisted Extract of Pleurospermum candollei to Evaluate its Functional Food Potential

  2025cites this paper
• Therapeutic Potential of Ficus benjamina: Phytochemical Identification and Investigation of Antimicrobial, Anticancer, Pro-Wound-Healing, and Anti-Inflammatory Properties

  2025cites this paper
• Solid Lipid Nanoparticles Encapsulating a Benzoxanthene Derivative in a Model of the Human Blood–Brain Barrier: Modulation of Angiogenic Parameters and Inflammation in Vascular Endothelial Growth Factor-Stimulated Angiogenesis

  2024cites this paper
• Systematic synthesis and identification of monolignol pathway metabolites.

  2024cites this paper
• Caffeic acid and its derivative caffeic acid phenethyl ester as potential therapeutic compounds for cardiovascular diseases: A systematic review

  2024cites this paper
• Parsing p-tolyloxy-1,3,4-oxadiazolepropanamides as 15-lipoxygenase inhibitors prop up by in vitro and in silico profiling including structure determination

  2023cites this paper
• Synthesis of alnustone-like diarylpentanoids via a 4 + 1 strategy and assessment of their potential anticancer activity

  2023cites this paper
• Click-designed vanilloid-triazole conjugates as dual inhibitors of AChE and Aβ aggregation

  2023cites this paper
• Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights

  2022cites this paper
• Actions of Caffeic Acid Loaded-Silver Nanoparticles on Blood Pressure, Oxidative Stress, and Antioxidants in Nitric Oxide Deficient Hypertensive Rats

  2022cites this paper
• Characterization and evaluation of Colombian propolis on the intestinal integrity of broilers

  2022cites this paper
• Ketone Analog of Caffeic Acid Phenethyl Ester Exhibits Antioxidant Activity via Activation of ERK-Dependent Nrf2 Pathway

  2022cites this paper
• Structure–Activity Relationship Studies of New Sinapic Acid Phenethyl Ester Analogues Targeting the Biosynthesis of 5-Lipoxygenase Products: The Role of Phenolic Moiety, Ester Function, and Bioisosterism

  2022cites this paper
• 5-Lipoxygenase as an emerging target against age-related brain disorders.

  2021cites this paper
• Effectiveness of CAPE in reducing vascular permeability after brain injury

  2021cites this paper
• Cardiovascular Effects of Caffeic Acid and Its Derivatives: A Comprehensive Review

  2020cites this paper
• Effects of caffeic acid phenethyl ester in reducing cerebral edema in rat subjects experiencing brain injury: An in vivo study

  2020cites this paper
• Avenanthramides as lipoxygenase inhibitors

  2020cites this paper
• Phenolic acid phenethylesters and their corresponding ketones: Inhibition of 5‐lipoxygenase and stability in human blood and HepaRG cells

  2019cites this paper
• 5-Lipoxygenase as a drug target: A review on trends in inhibitors structural design, SAR and mechanism based approach.

  2019cites this paper
• Caffeates and Caffeamides: Synthetic Methodologies and Their Antioxidant Properties

  2019cites this paper
• Structurally Related Edaravone Analogues: Synthesis, Antiradical, Antioxidant, and Copper-Chelating Properties.

  2019cites this paper
• Discovery of a novel 2,5-dihydroxycinnamic acid-based 5-lipoxygenase inhibitor that induces apoptosis and may impair autophagic flux in RCC4 renal cancer cells.

  2019cites this paper
• Design, synthesis and identification of novel coumaperine derivatives for inhibition of human 5-LOX: Antioxidant, pseudoperoxidase and docking studies.

  2019cites this paper
• Role of the 12‐lipoxygenase pathway in diabetes pathogenesis and complications

  2019cites this paper
• Sinapic acid phenethyl ester as a potent selective 5‐lipoxygenase inhibitor: Synthesis and structure–activity relationship

  2018cites this paper
• New Caffeic Acid Phenylethyl Ester Analogs Bearing Substituted Triazole: Synthesis and Structure-Activity Relationship Study towards 5-Lipoxygenase Inhibition

  2017cites this paper
• Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agents

  2017cites this paper
• Substituted Caffeic and Ferulic Acid Phenethyl Esters: Synthesis, Leukotrienes Biosynthesis Inhibition, and Cytotoxic Activity

  2017cites this paper
• New Hydroxycinnamic Acid Esters as Novel 5-Lipoxygenase Inhibitors That Affect Leukotriene Biosynthesis

  2017cites this paper